Buy Visomitin SkQ1 5ml Eye Drops
url: https://www.ebay.com/p/10034911144
Preventive and therapeutic effects of SkQ1-containing Visomitin eye drops against light-induced retinal degeneration
Yu. P. Novikova1 , O. S. Gancharova2 *, O. V. Eichler2 , P. P. Philippov2 , and E. N. Grigoryan DOI: 10.1134/S0006297914100113
https://link.springer.com/article/10.1134/S0006297914100113
Abstract—The human retina is constantly affected by light of varying intensity, this being especially true for photoreceptor cells and retinal pigment epithelium. Traditionally, photoinduced damages of the retina are induced by visible light of high intensity in albino rats using the LIRD (lightinduced retinal degeneration) model. This model allows study of pathological processes in the retina and the search for retinoprotectors preventing retinal photodamage. In addition, the etiology and mechanisms of retina damage in the LIRD model have much in common with the mechanisms of the development of age related retinal disorders, in particular, with agerelated macular degeneration (AMD). We have studied preventive and ther apeutic effects of Visomitin eye drops (based on the mitochondriatargeted antioxidant SkQ1) on albino rat retinas dam aged by bright light. In the first series of experiments, rats receiving Visomitin for two weeks prior to illumination demon strated significantly less expressed atrophic and degenerative changes in the retina compared to animals receiving similar drops with no SkQ1. In the second series, the illuminated rats were treated for two weeks with Visomitin or similar drops without SkQ1. The damaged retinas of the experimental animals were repaired much more effectively than those of the con trol animals. Therefore, we conclude that Visomitin SkQ1containing eye drops have pronounced preventive and therapeu tic effects on the photodamaged retina and might be recommended as a photoprotector and a pharmaceutical preparation for the treatment of AMD in combination with conventional medicines.
Key words: retina, photoreceptors, photodamage, SkQ1, Visomitin
Reactive oxygen species (ROS), which are mainly generated by mitochondrial electron transport [13], can cause considerable damage to various cell types. This is especially true for the retina, which is exposed to photon flux during the entire life of an organism, and in addition its cells are characterized by high rate of oxygen metabo lism and high content of polyunsaturated fatty acids [4, 5]. Thus, conditions are created for regular production of a large amount of ROS that damage retinal structures, especially photoreceptor cells – the rods and cones [6 11]. It has been demonstrated on many in vitro and in vivo models that the penetrating cation 10(6′plasto quinonyl)decyltriphenylphosphonium (SkQ1) has high antioxidant activity due to its ability to remove ROS from the mitochondrial matrix [1214]. According to our earlier data [15, 16], the antioxi dant SkQ1 has protective effect on the neural retina, reti nal pigment epithelium (RPE), and choroid cultivated in preparations of the posterior segment of albino rat eyes, significantly reducing cell death in these structures and preventing macrophage transformation of RPE cells. In the present study we examined the ability of Visomitin SkQ1containing eye drops to provide prophylactic and therapeutic effects on albino rat retina damaged by expo sure to high intensity light according to the LIRD (light induced retinal degeneration) model [17, 18]
MATERIALS AND METHODS
Visomitin eye drops were obtained from the Institute of Mitoengineering, Lomonosov Moscow State University. The composition of the eye drops (per 100 ml): 0.0155 mg SkQ1, 10 mg benzalkonium chloride, 200 mg oxypropyl methylcellulose, 900 mg sodium chlo ride, 810 mg sodium dihydrophosphate, 1.1635 g sodium hydrogen phosphate dodecahydrate, and water to total volume 100 ml. Animals. Healthy twomonthold female albino Wistar rats (n = 36) were used for the experiments, six of them serving as controls. Prior to the experiment, the ani mals were kept under normal vivarium conditions (12 h light/12 h dark); we conducted regular external inspec tion of their eyes. Upon completion of the experiment, the rats were decapitated under chloral hydrate (Sigma, USA) anesthesia (500 mg/kg intraperitoneally). All the procedures were consistent with the protocols approved by the Russian Academy of Sciences Commission on Bioethics and performed in compliance with the ethical rules of the European Directive FELASA2010. Damaging of albino rat retina using the LIRD model. Before illumination, the rats were kept in the dark for 14 h for dark adaptation of their eyes, and then they were exposed to bright light for 14 h. The highintensity visible light source was an NCDE 70W/DW RX7s metal halide lamp (NARVA, Germany) with the following specifica tions: power 70 W, luminous flux 50005500 lumens, color temperature 4000 K. The lamp was placed 2 m from the animal cages, which corresponded to intensity of reti na illumination of 25003000 lx. Preventive effect of Visomitin SkQ1containing eye drops on albino rat retina. Rats (n = 18) of the experi mental (n = 9) and control (n = 9) groups received, respectively, SkQ1containing eye drops or similar drops without SkQ1 (placebo) for 15 days; in both cases, one drop per day was placed in the left and right eyes of each animal. Upon completion of the course, the animals were illuminated with the light of high intensity, and then were kept in the dark for 3 h. Immediately thereafter, six rats from the experimental and six rats from the control groups were euthanized. The remaining animals (three from each group) were kept for 15 days under the usual conditions (without illumination or administration of the eye drops) and then were euthanized. Therapeutic effect of Visomitin SkQ1containing eye drops on albino rat retina. The rats (n = 12) were illumi nated with the highintensity light and then kept for 15 days under the usual light conditions. The experimental group (n = 6) of illuminated animals received SkQ1con taining eye drops, and the control group (n = 6) received drops of the same composition without SkQ1 (placebo); in both cases the animals received one drop per day in the left and right eyes. Upon completion of the 15days course of administration of the eye drops, the animals were euthanized. Histological processing. Eyeballs isolated immedi ately after decapitation of the animals were placed in a Bouin’s fixative solution, and after two days the posterior segment containing retina, choroid, and sclera was isolat ed. Fixed preparations of the eye posterior segment were then washed in 70% alcohol and were subjected to routine histological processing including dehydration in alcohols of increasing concentration and embedding the properly oriented samples in paraffin. Sagittal serial sections (500 from each eye, 7μm thick each) were obtained from the paraffin blocks using a microtome (Reichert, Austria). The sections fixed on slides (MenzelGlaser, Germany) were deparaffinized, rehydrated, stained with Carazzi’s hematoxylin and eosin following the standard protocol, and mounted in Canada balsam. Morphometric analysis. Serial histological prepara tions were studied using Vanox AH3 (Olympus, Japan), Jenaval (Carl Zeiss, Germany), and AxioScope A.1 (Carl Zeiss) microscopes. Microphotographs were obtained using an AxioCam MRc5 highresolution digital camera (Carl Zeiss). Viewing and processing of the micropho tographs, addition of scales, and morphometric measure ments were performed using the AxioVision 8.0 (Carl Zeiss) and Adobe Photoshop CS6 Extended (Adobe Systems, USA) softwares. The width of the outer nuclear retinal layer (ONL) was examined 3 h after photodamaging. To estimate the change in this parameter caused by the intense light, two retinal preparations were randomly chosen from each group of rats euthanized 3 h after photodamaging. Five hundred measurements of ONL width were carried out in 60 serial sections from each such preparation, in eight dif ferent areas from the dorsal to the ventral sides of the eye (two dorsoperipheral areas, two dorsocentral areas, two ventrocentral areas, and two ventroperipheral areas). ONL atrophic area size was evaluated 15 days after the highintensity illumination. For this, two retinal preparations with the most severe damage were selected from each group of rats euthanized 15 days after illumi nation. ONL atrophic area size was determined as the product of the number of consecutive sections with detected ONL atrophy, section width (7 μm) and the length of the atrophy zone (in μm) in each section. The length of the inner segments of photoreceptor cells was determined in the area of the highest lightsen sitivity on 60 sections randomly selected from each group. The data were processed to determine the statistically sig nificant differences of sample mean values using the Mann–Whitney test at p = 0.05. Results were calculated and plotted using the MS Office Excel and ORIGIN 8.1 programs
RESULTS
Retinal damage caused by bright light. The structure of the retina of intact albino rats (n = 6) was typical for healthy tissue [19]. Figure 1 shows that the neural retina (following the direction from its scleral to vitreal parts) consists of three nuclear layers containing neuronal cell bodies that are interleaved with two plexiform layers con
sisting of neuronal processes. The layers interacting with RPE are located closer to the sclera; they include the outer segments and bodies of photoreceptor cells that together form the outer retina. The outer plexiform layer, inner nuclear layer (INL) formed of interneuron bodies, and ganglion cell layer are located more vitreally. The inner plexiform layer is located between INL and gan glion cell layer, which together form the inner retina. Damages typical for the LIRD models [17, 18, 20 26] were found in the retina of albino rats exposed to illu mination with bright light (n = 9). Usually, morphologi cal manifestations of early photoinduced damages typical for this model are found in the outer retina 24 h after illumination. They include destruction of the photore ceptor layer, the initial stage of ONL thinning, pyknosis of photoreceptor nuclei, as well as vacuolization, migra tion, and phagocytic activity of RPE cells [17, 27, 28]. In our case, shortening and disorganization of outer and inner segments of photoreceptor cells and pyknosis of their nuclei were detected 3 h after photodamaging. Such changes in photoreceptor chromatin indicating the beginning of apoptosis caused the decrease in ONL thick ness, thinning of the outer plexiform retinal layer formed by photoreceptor axons, and shifting of the bodies of pho toreceptor cells in the scleral direction. In addition, some RPE cells migrated in the vitreal direction (Fig. 1) and phagocytized the damaged segments of photoreceptor cells (not shown). In some cases the neural retina was peeled off the RPE and choroid, demonstrating bucklings (not shown) due to accumulation of edema fluid and cel lular debris underneath. All the observed damages of the outer retina were of multifocal nature, which indicates unequal photosensi tivity of its different areas. ONL thinning detected 3 h after photodamaging showed that dorsocentral retinal area was most susceptible (Fig. 2). Relatively late photoinduced damages typical for the LIRD model are manifested in albino rat retinas several days to several weeks after exposure to bright light. These changes are present in outer retinal layers in the form of subtotal ONL atrophy due to apoptotic death of photore ceptors and in inner retinal layers. In the latter case, it is manifested in the formation of microneuromas and chan nels and shifting of INL neurons in the scleral direction, resulting in significant general restructuring of the retina [17, 18, 2024, 26]. In our experiments, 15 days after the illumination all the animals developed pronounced atroph ic changes in ONL and retinal plexiform layers as well as accompanying migration of ONL and INL cells in the vit real and scleral directions, respectively (Fig. 3). Atrophic loci were also observed in the RPE layer (not shown). In addition, compensatory processes involving pri marily the Müller glia of the neural retina developed in the albino rat retina during 15 days after its illumination with bright light. For example, in retinal areas adjacent to the areas of ONL atrophy, hypertrophy of glial cells processes could be observed that was manifested in increase in their thickness and number. Cysts and chan nels for draining the edema fluid were developing mainly in the INL. Microneuromas were detected in the INL – the clusters of neuronalphenotype cells and randomly arranged bundles of their processes (Fig. 3). Complete destruction of retinal cytoarchitectonics up to indistin guishability of its layers could be observed in the most severely affected retinal areas. Photodamageassociated changes of the ganglion cell layer (GCL) were less expressed, but death of cells of this layer was observed in about one third of the retinal samples obtained from the illuminated animals. All the detected late retinal changes were of multifocal character; damaged areas in the inner retina usually accom panied the atrophy and other damages in the outer retina. Preventive effect of Visomitin SkQ1containing eye drops on retina of albino rats subjected to illumination with bright light. In this series of the experiments, albino rats received Visomitin SkQ1containing drops (experimental group) or similar drops without SkQ1 (control group) for two weeks prior to the illumination. The state of retina in the experimental and control groups was compared after 3 h and 15 days to determine whether Visomitin had a preventive effect on the retina of illuminated animals. The severity of early and late pathological processes in the retina, typical for LIRD models, served as the criteria for this comparison. Death of photoreceptors whose bodies are located in the ONL, resulting in the reduction of this layer thickness, is one of the earliest events of lightinduced retinal damage. Comparison of ONL thickness in different areas of the reti nal preparations (n = 2) obtained from animals of experi mental and control groups, as well as from the intact rats, showed that ONL thickness was significantly greater in the experimental group (animals receiving Visomitin) than in the control group 3 h after illumination (Fig. 2), the effect of Visomitin being most pronounced in the central area of the retina. The degree of preservation of the outer and inner segments of photoreceptor cells, evaluated based on their size 3 h after illumination, was shown to be greater in rats from the experimental group both in peripheral and central retinal areas (not shown). Finally, Visomitin was shown to cause 3fold reduction in the number of atrophic and dystrophic RPE loci adjacent to the areas of ONL damage and photoreceptor cell death (when compared to the control, Table 1). In general, according to quantitative assessment of the state of retina in the control and experi mental samples of the posterior eye segment, the results of which are presented in Table 1, 3 h after illumination the state of retina remained close to intact in the vast majority of animals of the experimental group. Fifteen days after illumination, ONL multifocal atrophy was quite pronounced, and so we compared atro phy in the areas of this layer in experimental and control retinal samples using two samples from each group of rats. The average area size of ONL atrophy in the experimen tal group of animals was found to be significantly smaller than in the control (Fig. 4), i.e. late changes in the outer neural retina were also sensitive to the protective effect of Visomitin. The data presented in Table 1 indicate that the
same holds true for the late changes in RPE and inner retina. Areas of hypertrophy of the processes of Müller glial cells associated with the areas of ONL damage were present in the INL of the control samples (Fig. 3), where as in the experimental samples reactive Müller gliosis was far less pronounced. This is also true for the cases of such severe changes as the development of channels and microneuromas observed in the majority of control, but not in experimental retinal samples (Table 1). Therapeutic effect of Visomitin SkQ1containing eye drops on retina of albino rats exposed to illumination with bright light. In this series of the experiments, the rats were first illuminated with bright light, and then SkQ1con taining eye drops Visomitin (experimental group) or sim ilar drops but without SkQ1 (control group) were admin istered for two weeks. After 15 days, we compared the state of the retina in these groups to determine whether Visomitin has a therapeutic effect on the retina after the illumination of animals. Table 2 summarizes the results of quantitative evaluation of the late pathological changes in retinal samples from the control and experimental ani mals demonstrating the pronounced protective effect of Visomitin on the state of both outer and inner retina after lightinduced damage. Measuring the areas of ONL atrophy in the experi mental and control samples with the most pronounced changes (two samples from each group) showed that administration of Visomitin results in the significant reduction in the areas of ONL atrophy. Evaluation of the atrophic area size in this layer in experimental samples 15 days after illumination shows virtually complete absence of atrophic phenomena (Fig. 4). Visomitin also protects the inner segments of photoreceptor cells of the dorso central retinal area, which serve as targets for light induced damage from photoinduced shortening: the length of these segments in the experimental samples was 10 ± 1 μm, and in the control samples – 7 ± 1 μm. Visomitin caused threefold greater preservation of RPE compared to the control samples (Table 2). According to these criteria, Visomitin has a pronounced therapeutic effect on the outer retina of rats, and its administration largely prevents cell death and local RPE destruction. The inner retina of placeboreceiving rats demon strated pronounced changes in cytoarchitectonics, including the formation of channels to drain the edema fluid and microneuromas, six times more often than the retina of experimental samples (Table 2). Thus, Visomitininduced improvement of the state of the outer retina led to the reduction of pathological processes in the areas of the inner retina. It should be added that solitary lymphocytic inflam matory infiltrates were found in the choroid of control, but not in the experimental samples of the eye posterior segment (not shown).
DISCUSSION The LIRD (lightinduced retinal degeneration) model is often used when studying lightdependent dam ages of the retinas of animals [17, 18]. According to this model, albino rat eyes are exposed to shortterm illumina tion with light of high intensity (20003000 lx) or long term illumination with light of low or medium intensity (200500 lx) [20, 21]. Albino rats are used for the experi ments because the light sensitivity of their retina is greater than that of pigmented animals due to the absence of melanin pigment in the albino eyes (melanin protects reti nal structures against excessive light) [20, 22]. The uniqueness of the LIRD model is that in addition to the early damages in photoreceptor cells [24], it presents delayed damages in the RPE–Bruch’s membrane– choroid complex and even later compensatoryadaptive processes in the inner retinal layers [23]. Since intense illumination causes rather fast changes in retinal morphol ogy, histological study of eye sections is commonly per formed when using the LIRD model [17, 21, 23]. The degree of retinal damage in the different versions of the LIRD model varies and depends on a number of factors such as light intensity, exposure time, light source, as well as line, gender, age, and body temperature of the animals [17, 29]. For example, it is better to use female rats as their retinas are more sensitive to lightinduced damage [29]. The dynamics of the destructive changes in the two major retinal cell populations serving as targets for light effects (photoreceptors and RPE cells) can also vary [30]. Numerous studies have been dedicated to research on molecular and cellular mechanisms that underlie the pho toinduced damage of retinal cells [31] and the search for compounds that could prevent or at least reduce such damages. Since oxidative stress is an important compo nent of the pathogenesis of photoinduced retinal damage, this search is mainly focused on compounds with antioxi dant properties. For example, it was shown that curcumin and the green tea component epigallocatechin gallate, when used perorally, could reduce the risk of rat retina damage caused by bright light [32, 33]. Synthetic antioxi dants such as TEMPOLH can also protect photoreceptor cells, reducing the level of lipid peroxidation in them [34]. It has been demonstrated on a large number of in vitro and in vivo models that penetrating cation SkQ1 has high antioxidant activity [1214]. However, the mecha nism of SkQ1 effect on eye retina damaged by bright light remained unknown. We investigated this question in two series of experiments with the LIRD model [17, 18] using Visomitin SkQ1containing eye drops. In the first series, when we studied the preventive effect of Visomitin on the retina, albino rats received Visomitin for two weeks, then they were illuminated with bright light and the morphol ogy of their retina was analyzed 3 h and 15 days after the illumination. In the second series, when we studied the therapeutic effect of Visomitin on the retina, rats were first illuminated with bright light, then they received Visomitin for two weeks, and then the morphology of their retinas was analyzed. In both cases, the control ani mals received eye drops of the same composition but without SkQ1 following the same protocols. Experiments on the preventive effect of Visomitin have shown (Table 1 and Figs. 2 and 4) that these eye drops have a pronounced protective effect on the albino rat retina, reducing the risk of the formation of early lightinduced pathological changes and preventing their further development. Visomitin also inhibits the expres sion of late lightinduced retinal changes, in particular, reactive gliosis, which increases the number and thickness of the processes of Müller glia cells. These results are con sistent with data found in literature according to which proliferative activity of Müller glia cells and their specific density is increased in INL areas adjacent to outer retinal damages [35, 36]. Glia is known to be involved in the pro duction and transport of a number of metabolites and neurotrophic factors in the retina [37]. It is also possible that retinal glial cells can be transformed into poorly dif ferentiated precursors capable of differentiating into reti nal neurons under certain conditions [38]. It can be assumed that retinal gliosis described in our experiments can serve as a compensatory event, and Visomitincaused reduction in gliosis level reflects the lower level of photo damage. According to the literature, lightinduced damage of the retina (which is normally an immuneprivileged zone) disturbs the blood–retinal barrier [39], resulting in the possibility of inflammatory infiltration of the retina [40]. In our experiments, illumination of the control rats led to the development of solitary lymphocytic infiltrates in the choroid of their retinas, which indicated damage to the blood–retinal barrier. Visomitin administration pre vented the formation of such infiltrates, indicating the protective effect of the eye drops on this barrier. Experiments studying the therapeutic effect of Visomitin have shown (Table 2 and Fig. 4) that these eye drops reduce the risk of the development of late light induced pathological changes in the retina and lead to the preservation of the population of photoreceptor cells. Photoinduced death of these cells is known to occur not at the moment of illumination, but gradually over some time. During subsequent dark adaptation, photoreceptor cells start entering caspasedependent apoptosis [41], leading to compensatory pathological changes in RPE [18]. The described therapeutic effect of Visomitin on the lightdamaged retina can be explained by the protection of photoreceptor cells against apoptosis. In particular, the data obtained on cell cultures support this hypothesis. According to these data, SkQ and other mitochondria addressed antioxidants prevent photoinduced apoptosis of HeLa cells by reducing the level of oxidative stress in them [42, 43]. It is also possible that the therapeutic effect of SkQ1 is connected with the restoration of the outer segments of some photoreceptor cells after their damage. For example, there is some evidence of the possibility of DNA repair in photoreceptor cells and reversibility of lightinduced changes [44]. Moreover, restoration of outer photoreceptor segments in rats [4547] and humans [48] is possible even in case of complete destruction of these photoreceptor segments as long as their perikaryon and cell nuclei remain intact. These observations suggest that Visomitin SkQ1containing eye drops will be an effective medication to stimulate restoration mechanisms of retinal cells. The described degenerative and atrophic light induced retinal damages are typical for LIRD models in their nature and rate of development [17, 18, 2024]. These damages were of multifocal character, being pres ent in both peripheral and central retinal areas. The dorsocentral retinal area was shown to be particularly prone to lightinduced damage, which is consistent with its maximal sensitivity to light in rats and with data on topographic studies on the LIRD model [29, 49]. The dorsocentral area of the rat retina can be considered as a functional analog of the human retinal macula, the area of sharpest vision. In this context, it is particularly impor tant to note that etiology and mechanisms of animal reti na damage under the conditions of the LIRD model have much in common with the mechanisms of the develop ment of agerelated retinal diseases. For this reason, the LIRD model is widely used in research on new approach es to prevention and treatment of agerelated eye diseases [50], in particular, agerelated macular degeneration, AMD [24, 33, 51], since constant exposure of the human retina to sunlight is considered to be one of the factors contributing to the development of AMD [4, 52, 53]. The data of the presented study indicate the ability of Visomitin SkQ1containing eye drops to have pro nounced preventive and therapeutic effects on the retina of rats exposed to bright light. Moreover, taking into account the previously demonstrated therapeutic effect of SkQ1 on AMD development in rapidly aging OXYS rats [54, 55], Visomitin can be considered as a potential med ical preparation for the prevention and treatment of human retina damages, in particular, those accompany ing agerelated retinal macular degeneration
For search engines
Eye treatments. Vision improvements. Eyes, Researches, The science, Scientific breakthroughs in the world, Lenses, Glaucoma, Age-related macular degeneration, Dry eye syndrome (DES), Non-infectious uveitis. Cataract Treatment. Cataract. Best Eye Treatment Google Scholar PubMed Scopus Web of Science ScienceDirect Baidu SciELO EBSCOHost doaj Directory of Open Access Journals Academia Springer Science+Business Media Elsevier Thieme Medical Publishers ResearchGate Open Library Wiley Online Library Palgrave Macmillan Cambridge University Press Oxford University Press Routledge Axel Springer SE Emerald Group Publishing Princeton University Press Yale University Press MIT Press Academic Press Taylor and Francis CRC Press McGraw Hill Education Barnes and Noble Pearson Education BBC British Broadcasting Corporation Harvard University Random House SAGE Publications HarperCollins Imperial College London safe eye treatmen
For search engines
Eye treatments. Vision improvements. Eyes, Researches, The science, Scientific breakthroughs in the world, Lenses, Glaucoma, Age-related macular degeneration, Dry eye syndrome (DES), Non-infectious uveitis. Cataract Treatment. Cataract. Best Eye Treatment Google Scholar PubMed Scopus Web of Science ScienceDirect Baidu SciELO EBSCOHost doaj Directory of Open Access Journals Academia Springer Science+Business Media Elsevier Thieme Medical Publishers ResearchGate Open Library Wiley Online Library Palgrave Macmillan Cambridge University Press Oxford University Press Routledge Axel Springer SE Emerald Group Publishing Princeton University Press Yale University Press MIT Press Academic Press Taylor and Francis CRC Press McGraw Hill Education Barnes and Noble Pearson Education BBC British Broadcasting Corporation Harvard University Random House SAGE Publications HarperCollins Imperial College London safe eye treatmen skq1 eye drops
For search engines / Tag Cloud:
Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Burundi, Côte d’Ivoire, Cabo Verde, Cambodia, Cameroon, Canada, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo (Congo-Brazzaville), Costa Rica, Croatia, Cuba, Cyprus, Czechia (Czech Republic), Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Eswatini (fmr. “Swaziland”), Ethiopia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Holy See, Honduras, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Morocco, Mozambique, Myanmar (formerly Burma), Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, North Korea, North Macedonia, Norway, Oman, Pakistan, Palau, Palestine State, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, South Korea, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Sweden, Switzerland, Syria, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States of America, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, Yemen, Zambia, Zimbabwe, USA, North America, South America, Europe / Amazon / Ebay / Etsy
For search engines / United States / USA
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming
Alameda Albany Berkeley Dublin Emeryville Fremont Hayward Livermore Newark Oakland Piedmont Pleasanton San Leandro Union City Amador Ione Jackson Plymouth Sutter Creek Biggs Biggs Chico Gridley Oroville Paradise Angels Camp Colusa Williams Antioch Brentwood Clayton Concord Danville El Cerrito Hercules Lafayette Martinez Moraga Oakley Orinda Pinole Pittsburg Pleasant Hill Richmond San Pablo San Ramon Walnut Creek Crescent City Placerville South Lake Tahoe Clovis Coalinga Firebaugh Fowler Fresno Huron Kerman Kingsburg Mendota Orange Cove Parlier Reedley Sanger San Joaquin Selma Orland Willows Arcata Blue Lake Eureka Ferndale Fortuna Rio Dell Trinidad Brawley Calexico Calipatria El Centro Holtville Imperial Westmorland Bishop Arvin Arvin Bakersfield California City Delano Maricopa Mcfarland Ridgecrest Shafter Taft Tehachapi Wasco Avenal Corcoran Hanford Lemoore Clearlake Lakeport Susanville Agoura Hills Alhambra Arcadia Artesia Avalon Azusa Baldwin Park Bell Bellflower Bell Gardens Beverly Hills Bradbury Burbank Calabasas Carson Cerritos Claremont Commerce Compton Covina Cudahy Culver City Diamond Bar Downey Duarte El Monte El Segundo Gardena Glendale Glendora Hawaiian Gardens Hawthorne Hermosa Beach Hidden Hills Huntington Park Industry Inglewood Irwindale La Canada Flintridge La Habra Heights Lakewood La Mirada Lancaster La Puente La Verne Lawndale Lomita Long Beach Los Angeles Lynwood Malibu Manhattan Beach Maywood Monrovia Montebello Monterey Park Norwalk Palmdale Palos Verdes Estates Paramount Pasadena Pico Rivera Pomona Rancho Palos Verdes Redondo Beach Rolling Hills Rolling Hills Estates Rosemead San Dimas San Fernando San Gabriel San Marino Santa Clarita Santa Fe Springs Santa Monica Sierra Madre Signal Hill South El Monte South Gate South Pasadena Temple City Torrance Vernon Walnut West Covina West Hollywood Westlake Village Whittier Chowchilla Madera Belvedere Corte Madera Fairfax Larkspur Mill Valley Novato Ross San Anselmo San Rafael Sausalito Tiburon Fort Bragg Point Arena Ukiah Willits Atwater Dos Palos Gustine Livingston Los Banos Merced Alturas Mammoth Lakes Carmel-By-The-Sea Del Rey Oaks Gonzales Greenfield King City Marina Monterey Pacific Grove Salinas Sand City Seaside Soledad American Canyon Calistoga Napa St Helena Yountville Grass Valley Nevada City Truckee Aliso Viejo Anaheim Brea Buena Park Costa Mesa Cypress Dana Point Fountain Valley Fullerton Garden Grove Huntington Beach Irvine Laguna Beach Laguna Hills Laguna Niguel Laguna Woods La Habra Lake Forest La Palma Los Alamitos Mission Viejo Newport Beach Orange Placentia Rancho Santa Margarita San Clemente San Juan Capistrano Santa Ana Seal Beach Stanton Tustin Villa Park Westminster Yorba Linda Auburn Colfax Lincoln Loomis Rocklin Roseville Portola Banning Beaumont Blythe Calimesa Canyon Lake Cathedral City Coachella Corona Desert Hot Springs Eastvale Hemet Indian Wells Indio Jurupa Valley Lake Elsinore La Quinta Menifee Moreno Valley Murrieta Norco Palm Desert Palm Springs Perris Rancho Mirage Riverside San Jacinto Temecula Wildomar Citrus Heights Elk Grove Folsom Galt Isleton Rancho Cordova Sacramento Hollister San Juan Bautista Adelanto Apple Valley Barstow Big Bear Lake Chino Chino Hills Colton Fontana Grand Terrace Hesperia Highland Loma Linda Montclair Needles Ontario Rancho Cucamonga Redlands Rialto San Bernardino Twentynine Palms Upland Victorville Yucaipa Yucca Valley Carlsbad Chula Vista Coronado Del Mar El Cajon Encinitas Escondido Imperial Beach La Mesa Lemon Grove National City Oceanside Poway San Diego San Marcos Santee Solana Beach Vista San Francisco Escalon Lathrop Lodi Manteca Ripon Stockton Tracy Arroyo Grande Atascadero El Paso De Robles Grover Beach Morro Bay Pismo Beach San Luis Obispo Atherton Belmont Brisbane Burlingame Colma Daly City East Palo Alto Foster City Half Moon Bay Hillsborough Menlo Park Millbrae Pacifica Portola Valley Redwood City San Bruno San Carlos San Mateo South San Francisco Woodside Buellton Carpinteria Goleta Guadalupe Lompoc Santa Barbara Santa Maria Solvang Campbell Cupertino Gilroy Los Altos Los Altos Hills Los Gatos Milpitas Monte Sereno Morgan Hill Mountain View Palo Alto San Jose Santa Clara Saratoga Sunnyvale Capitola Santa Cruz Scotts Valley Watsonville Anderson Redding Shasta Lake Loyalton Dorris Dunsmuir Etna Fort Jones Montague Mount Shasta Tulelake Weed Yreka Benicia Dixon Fairfield Rio Vista Suisun City Vacaville Vallejo Cloverdale Cotati Healdsburg Petaluma Rohnert Park Santa Rosa Sebastopol Sonoma Windsor Ceres Hughson Modesto Newman Oakdale Patterson Riverbank Turlock Waterford Live Oak Yuba City Corning Red Bluff Tehama Dinuba Exeter Farmersville Lindsay Porterville Tulare Visalia Woodlake Sonora Camarillo Fillmore Moorpark Ojai Oxnard Port Hueneme Santa Paula Simi Valley Thousand Oaks Ventura Davis West Sacramento Winters Woodland Marysville Wheatland Las Vegas Henderson Reno North Las Vegas Paradise Spring Valley Sunrise Manor Enterprise Sparks Carson City Whitney Pahrump Winchester Summerlin South Sun Valley Elko Fernley Mesquite Spanish Springs Boulder City Spring Creek Gardnerville Ranchos Cold Springs Dayton Incline Village Fallon
Laughlin Winnemucca Moapa Valley Gardnerville Indian Hills Johnson Lane Lemmon Valley Silver Springs West Wendover Ely Battle Mountain Nellis AFB Minden Yerington Hawthorne Washoe Valley Kingsbury Carlin Tonopah Lovelock Stagecoac Sandy Valley Topaz Ranch Estates Smith Valley East Valley Bunkerville Pioche Mogul Ruhenstroth Golden Valley Verd Jackpot Panaca Owyhee Alamo Schurz Wells Round Hill Village Stateline McGill Caliente Indian Springs Beatty Wadsworth 792Virginia City Grass Valley Moapa Town Genoa Fish Springs Osino Eureka and Crescent Valley Carter Springs Fallon Station Zephyr Cove Mount Charleston Lakeridge Fort McDermitt Blue Diamond Dyer Skyland Searchlight Walker Lake Goldfield Sutcliffe Lamoille Double Spring Glenbrook Nixon Imlay Topaz Lake Crystal Bay Mina TIE Humboldt River Ranch and Silver City Silver Peak Empire Ruth McDermitt Austin Cal-Nev-Ari TIE Gabbs and Lund Kingston Valmy Golconda Rachel Orovada Hiko Montello Baker Paradise Valley Bennett Springs Oasis Logan Creek TIE Gerlach and Nelson Beaverdam Preston
For search engines skulachev ions Plastoquinonyl-decyl-triphenylphosphonium bromide Aging*Animals Biological Transport Blindness / drug therapy Blindness / physiopathology Blindness / veterinary Cats Dogs Eye Diseases / drug therapy Eye Diseases / physiopathology Eye Diseases / prevention & control Eye Diseases / veterinary* Female Horses Best Drops In Vitro Techniques Male Mitochondria / chemistry Mitochondria / drug effects
Mitochondria / metabolism* Plastoquinone / analogs & derivatives*
Plastoquinone / metabolism Plastoquinone / pharmacology Progeria / chemically induced Progeria / physiopathology Progeria / veterinary Rabbits Horses dog cat Rats Key Words: Glaucoma, Rabbit Model, Mitochondria-Targeted Antioxidant, Reversal Of Lesions, SkQ1 Reactive Oxygen Species / metabolism Retina / drug effects Retina / metabolism Retina / physiopatholog AMD: age-related macular degeneration GCL: ganglion cell laye INL: inner nuclear layer IPL: inner plexiform layer LIRD: light-induced retinal degeneration ONL: outer nuclear layer OPL: outer plexiform layer PL: photoreceptor layer RPE: retinal pigment epithelium ROS: reactive oxygen species Key words: retina, photoreceptors, photodamage, SkQ1, Visomitin Mitotech Skq1 Vizomitin Mitotech Skq1 Vizomitin REFERENCES 1. Augustin AJ, Spitznas M, Kaviani N, Meller D, Koch FH, Grus F, et al. Oxidative reactions in the tear fluid of patients suffering from dry eyes. Graefes Atch Clin Exp Ophthalmol. 1995;233(11):694–8. 2. Bakeeva LE, Barskov IV, Egorov MV, et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochem Biokhimiia. 2008;73(12):1288–99. 3. Baudouin C. The pathology of dry eye. Surv Ophthalmol. 2001;45(Suppl. 2):S211–20. 4. Behndig A, Svensson B, Marklund SL, Karlsson K. Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci. 1998;39(3):471–5. 5. Brzheskiy VV, Alekseev VN, Gusarevich OG, et al. Results of a multicenter, randomized, double-masked, placebo-controlled clinical study of the efficacy and safety of Visomitin eye drops in patients with dry eye syndrome. Adv Ther. 2015;32:1263–79. doi:10.1007/s12325–015- 0273–6 6. Deng R, Hua X, Li J, Chi W, Zhang Z, Lu F, Zhang L, Pflugfelder S, Li D-Q. Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells. PLoS One. 2015;10(5): e0126561. doi:10.1371/journal.pone0126561. 7. Dry Eye Workshop (DEWS) Committee. 2007 report of the international dry eye workshop (DEWS. Ocular Surf. 2007;5(2):65–204. 8. Higuchi A, Inoue H, Kawakita T, Ogishima T, Tsubota K. Selenium compound protects corneal epithelium against oxidative stress. PLoS One. 2012;7(9):e45612. doi:10.1371/journal.pone. 0045612. 9. Imamura Y, Noda S, Hashizume K, Shinoda K, Yamaguchi M, Uchiyama S, et al. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci. 2006;103(30):11282–7. Kelso G, Porteous C, Coulter C, Hughes G, Porteous W, Ledgerwood E, Smith R, Murphy M. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem. 2001;276: 4588–96. 11. Kolosova NG, Stefanova NA, Muraleva NA, Skulachev VP. The mitochondria-targeted antioxidant SkQ1 but not N-acetylcysteine reverses aging-related biomarkers in rats. Aging. 2012;4(10):686–94. 12. Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997;416:15–8. 13. Lemp MA. Report of the National Eye Institute/ industry workshop on Clinical Trials in Dry Eye. CLAO J. 1995;21:221–32. 14. Markovets AM, Fursova AZ, Kolosova NG. Therapeutic action of the mitochondriatargeted antioxidant SkQ1 on retinopathy in OXYS rats linked with improvement of VEGF and PEDF gene expression. PLoS One. 2011;6(7):e21682. 15. Messmer E. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015;112:71–82. 16. Muraleva NA, Kozhevnikova OS, Zhdankina AA, Stefanova NA, Karamysheva TV, Fursova AZ, et al. The mitochondria-targeted antioxidant SkQ1 restores alphaB-crystallin expression and protects against AMD-like retinopathy in OXYS rats. Cell cycle (Georgetown, Tex). 2014;13(22): 3499–505. 17. Nakamura S, Shibuya M, Nakashima H, Hisamura R, Masuda N, Imagawa T, et al. Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. IOVS. 2007;48(4): 1552–8. 18. Ousler GW, Gomes PJ, Welch D, Abelson MB. Methodologies for the study of ocular surface disease. Ocular Surf. 2005;3(3):143–54. 19. Saprunova VB, Lelekova MA, Kolosova NG, Bakeeva LE. SkQ1 slows development of age-dependent destructive processes in retina and vascular layer of eyes of wistar and OXYS rats. Biochem Biokhimiia. 2012;77(6):648–58. 20. Saprunova V, Pilipenko D, Alexeevsky A, Fursova A, Kolosova N, Bakeeva L. Lipofuscin granule dynamics during development of age-related macular degeneration. Biochem Biokhimiia. 2010;75(2):130–8. 21. Schaumberg D, Dana R, Buring J, Sullivan D. Prevalence of dry eye disease among US men: estimates from the Physicians’ Health Studies. Arch Ophthalmol. 2009;127(6):763–8. 22. Schaumberg D, Sullivan D, Buring J, Dana M. Prevalence of dry eye syndrome among US women. Am J Ophtahlmol. 2003;136(2):318–26. 23. Sheppard J, Torkildsen G, Lonsdale J, D’Ambrosio F, McLaurin E, Eiferman R, Kennedy K, Semba C. Lifitegrast ophthalmic solution 5.0 % for treatment of dry eye disease. Ophthalmology. 2014;121(2):475–83. 24. Shimmura S, Suematsu M, Shimoyama M, Tsubota K, Oguchi Y, Ishimura Y. Subthreshold UV radiation-induced peroxide formation in cultured corneal epithelial cells: the protective effects of lactoferrin. Exp Eye Res. 1996;63(5):519–26. 25. Skulachev VP. Cationic antioxidants as a powerful tool against mitochondrial oxidative stress. Biochem Biophys Res Commun. 2013;441(2):275–9. 26. Skulachev VP. What is ‘‘phenoptosis’’ and how to fight it? Biochem Biokhimiia. 2012;77(7):689–706. 27. Skulachev M, Antonenko Y, Anisimov V, Chernyak B, Cherepanov D, Chistyakov V, Egorov M, Kolosova N, Korshunova G, Lyamzaev K, Plotnikov E, Roginsky V, Savchenko A, Severina II, Severin F, Shkurat T, Tashlitsky V, Shidlovsky K, Vyssokikh M, Zamyatnin A Jr, Zorov D, Skulachev V. Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies. Curr Drug Targets. 2011;12:800–26. 28. Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, et al. An attempt to prevent senescence: a mitochondrial approach. Biochim Biophys Acta. 2009;1787(5):437–61. 29. Skulachev VP. Functions of mitochondria: from intracellular power stations to mediators of a senescence program. Cell Mol Life Sci. 2009;66(11–12):1785–93. 30. Snytnikova O, Tsentalovich Y, Stefanova N, Fursova A, Kaptein R, Sagdeev R, et al. The therapeutic effect of mitochondria-targeted antioxidant SkQ1 and Cistanche deserticola is associated with increased levels of tryptophan and kynurenine in the rat lens. Dokl Biochem Biophys. 2012;447:300–3. 31. Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012;130(1):90–100. 32. Wakamatsu TH, Dogru M, Matsumoto Y, Kojima T, Kaido M, Ibrahim OM, et al. Evaluation of lipid oxidative stress status in Sjogren syndrome patients. IOVS. 2013;54:201–10.
Wakamatsu TH, Dogru M, Tsubota K. Tearful relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol. 2008;71(6 Suppl):72–9. 34. Wakamatsu T, Dogru M, Sasaki Y, Ward S, Imamura Y. Histopathological alterations in senescent Cu, Zn-superoxide dismutase-1 (Sod-1)-knock-out mice: a new model for dry eye. In: 5th international conference on the tear film and ocular surface, Taormina, Italy, 4–9 September 2007. 35. Whitlock A, Belen L, Violette K, Brackett J, Ousler G, Perekhvatova N. Evaluation of topical SKQ1 in a murine CAETM model of dry eye disease. Abstract/poster presentation at The international symposium on ocular pharmacology and therapeutics 10th ISOPT clinical symposium, Paris, France, 7–10 March 2013. 36. Yani EV, Katargina LA, Chesnokova NB, Beznos OV, Savchenko AYU, Vygodin VA, Gudkova EYU, Zamyatnin AA, Skulachev MV. The first experience of using the drug Vizomitin in the treatment of dry eyes. Pract Med (Russia). 2012;4(59):134–7. 37. Yeh S, Song XJ, Farley W, et al. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci. 2003;44:124–9. 38. Zinovkin RA, Romaschenko VP, Galkin II, Zakharova VV, Pletjushkina OY, Chernyak BV, Popova EN. Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium. Aging. 2014;6(8):661–74. Купить США, amazon купить, vizomitin eae drops amazon, vizomitin eae drops uk, vizomitin eae drops united kingdom, visomitin eye drops reviews, visomitin eye drops canada, visomitin skq1 eye drops, visomitin cataract eye drops, visomitin eye drops buy.
Over-the-counter drug Drug legal status, Dry eye Medical condition, CVS Pharmacy Retail company, CVS Health Healthcare company, systane eye drops, CVS Photo Topic, Dry eye syndrome Syndrome, Conjunctivitis , Tears Body water, Contact lens, Walgreens, Refresh, Allergy, Antihistamine , Ketotifen , Olopatadine, Lubricant, Artificial tears, Medical prescription, Bausch + Lomb Alaway Antihistamine Eye Drops, SYSTANE , Solution, Tears, Zaditor Antihistamine Eye Drops, Glaucoma, Red eye, Cataract, pataday eye drops, Seattle-Tacoma WA100, Yakima-Pasco-Richland-Kennewick WA97, Spokane WA62, Portland OR, Dry eye syndrome,Breakout, Dry eye syndrome,Breakout, Red,Breakout, Red eye,Breakout, Artificial tears,Breakout, Ophthalmology, Bausch + Lomb LUMIFY, Rohto, Adverse effect , Contact lens, eye drops for dry eyes, best eye drops, dog eye drops, pink eye, pink eye drops, refresh eye drops, pataday eye drops, allergy eye drops, zaditor eye drops, lumify eye drops, stye eye drops, prednisolone eye drops, restasis eye drops, alaway eye drops, steroid eye drops, eye drops for contacts, atropine eye drops, clear eyes eye drops, best dry eye drops, visine eye drops, antihistamine eye drops, preservative free eye drops, Palm Springs , Los Angeles , San Diego , Fresno-Visalia , Monterey-Salinas , Bakersfield , San Francisco-Oakland-San Jose , Santa Barbara-Santa Maria-San Luis Obispo , Sacramento-Stockton-Modesto , Chico-Redding , Yuma AZ-El Centro , Medford-Klamath Falls , Reno NV, Eureka , Reno , Las Vegas , Salt Lake City , , Eye drop, Eye, Drop, Conjunctivitis, Dose, Over-the-counter drug, Dry eye syndrome, Bausch + Lomb LUMIFY, Allergy, Dry eye, Olopatadine, Red eye, Red, Zaditor Antihistamine Eye Drops, SYSTANE, Visual perception, Refresh, Stye, Ketotifen, Visine, Contact lens, Similasan, Tears, Eye infection, , Zaditor Antihistamine Eye Drops,Breakout, SYSTANE,Breakout, Stye,Breakout, Similasan,Breakout, Tears,Breakout, Olopatadine, Over-the-counter drug, Bausch + Lomb LUMIFY, Tucson (Sierra Vista) AZ,100, Phoenix AZ,75, Yuma AZ-El Centro CA,28, Cataract,Breakout, Latanoprost,Breakout, Zaditor Antihistamine Eye Drops,Breakout, Visine,Breakout, SYSTANE,Breakout, Ingredient,Breakout, Can-C,Breakout, Rohto,Breakout, Bausch + Lomb LUMIFY,+450%, Over-the-counter drug,+450%, Ketotifen,+300%, Antihistamine,+190%, Dry eye syndrome,+190%, Steroid,+180%, Stye,+180%, Prednisolone,+140%, Olopatadine,+140%, Dry eye,+120%, Timolol,+90%, Refresh,+50%, Conjunctivitis,+50%, Burn,+40%, Cyclosporine,+40%, Lens,+40%, Glaucoma,+40%, Eyelid,Breakout, Bausch + Lomb LUMIFY,Breakout, Cataract,Breakout, Tears,Breakout, Olopatadine,Breakout, Cataract surgery,Breakout, Stye,Breakout, Over-the-counter drug,+170%, Ketotifen,+80%, Eye,100, Eye drop,90, Drop,75, Dry eye syndrome,8, Contact lens,8, Preservative,6, Over-the-counter drug,6, Allergy,6, Dry eye,6, Eyelid,4, Bausch + Lomb LUMIFY,4, Cataract,4, Ketotifen,4, Tears,4, Olopatadine,2, Cataract surgery,2, Conjunctivitis,2, Stye,2, Red,2, Adverse effect,2, Boise ID,100, Idaho Falls-Pocatello ID,73, Twin Falls ID,72, Spokane WA,18, Great Falls MT,100, Billings, MT,84, Missoula MT,60, Butte-Bozeman MT,45, Glendive MT,, Helena MT,, Minot-Bismarck-Dickinson(Williston) ND,, Cheyenne WY-Scottsbluff NE,100, Billings, MT,16, Rapid City SD,11, Idaho Falls-Pocatello ID,3, Salt Lake City UT,3, Denver CO,2, Casper-Riverton WY,, Grand Junction-Montrose CO,100, Colorado Springs-Pueblo CO,95, Denver CO,85, Albuquerque-Santa Fe NM,100, El Paso TX,17, Amarillo TX,9, Minot-Bismarck-Dickinson(Williston) ND,100, Fargo-Valley City ND,67, Rapid City SD,100, Sioux Falls(Mitchell) SD,62, Lincoln & Hastings-Kearney NE,100, Omaha NE,84, Sioux City IA,15, Cheyenne WY-Scottsbluff NE,12, Sioux Falls(Mitchell) SD,3, Denver CO,<1, North Platte NE,, Topeka KS,100, Wichita-Hutchinson KS,82, Joplin MO-Pittsburg KS,31, Kansas City MO,27, St. Joseph MO,, Oklahoma City OK,100, Tulsa OK,94, Sherman TX-Ada OK,68, Wichita Falls TX & Lawton OK,67, Ft. Smith-Fayetteville-Springdale-Rogers AR,6, Amarillo TX,4, Besifloxacin, Cromoglicic acid, Gatifloxacin,Breakout, Bimatoprost,Breakout, Sulfacetamide,Breakout, Cat\’s eye,Breakout, Eye examination,Breakout, Hydrogen peroxide contact solutions, Beaumont-Port Arthur TX,100, Tyler-Longview(Lufkin & Nacogdoches) TX,87, San Antonio TX,78, Abilene-Sweetwater TX,77, Dallas-Ft. Worth TX,72, Odessa-Midland TX,72, Houston TX,72, El Paso TX,70, Laredo TX,67, Lubbock TX,67, Harlingen-Weslaco-Brownsville-McAllen TX,64, Austin TX,63, Waco-Temple-Bryan TX,60, Corpus Christi TX,55, San Angelo TX,49, Amarillo TX,41, Sherman TX-Ada OK,35, Victoria TX,31, Wichita Falls TX & Lawton OK,24, Shreveport LA,22, Solution, Bimatoprost, Serum, Pharmaceutical drug, Over-the-counter drug, Rochester MN-Mason City IA-Austin MN,100, Minneapolis-St. Paul MN,82, Duluth MN-Superior WI,55, Mankato MN,46, Fargo-Valley City ND,26, La Crosse-Eau Claire WI,3, Moxifloxacin , Cedar Rapids-Waterloo-Iowa City & Dubuque IA,100, Des Moines-Ames IA,76, Davenport IA-Rock Island-Moline IL,60, Sioux City IA,57, Rochester MN-Mason City IA-Austin MN,25, Omaha NE,24, Ottumwa IA-Kirksville MO,, St. Louis MO,100, Springfield MO,95, Columbia-Jefferson City MO,93, Kansas City MO,87, Joplin MO-Pittsburg KS,47, Paducah KY-Cape Girardeau MO-Harrisburg-Mount Vernon IL,35, Quincy IL-Hannibal MO-Keokuk IA,12, St. Joseph MO,, Ottumwa IA-Kirksville MO,, Eyelid, Itch, Therapy, Atropine, Jonesboro AR,100, Little Rock-Pine Bluff AR,58, Ft. Smith-Fayetteville-Springdale-Rogers AR,56, Shreveport LA,13, Springfield MO,8, Monroe LA-El Dorado AR,7, Memphis TN,5, Jonesboro AR,100, Little Rock-Pine Bluff AR,58, Ft. Smith-Fayetteville-Springdale-Rogers AR,56, Shreveport LA,13, Springfield MO,8, Monroe LA-El Dorado AR,7, Memphis TN,5, Lake Charles LA,100, New Orleans LA,72, Baton Rouge LA,67, Lafayette LA,64, Alexandria LA,61, Monroe LA-El Dorado AR,55, Shreveport LA,36, Bimatoprost,Breakout, Moxifloxacin,Breakout, Timolol, Lake Charles LA,100, New Orleans LA,72, Baton Rouge LA,67, Lafayette LA,64, Alexandria LA,61, Monroe LA-El Dorado AR,55, Shreveport LA,36, Wausau-Rhinelander WI,100, La Crosse-Eau Claire WI,72, Green Bay-Appleton WI,72, Milwaukee WI,64, Madison WI,63, Duluth MN-Superior WI,4, Minneapolis-St. Paul MN,3, Polymyxin B,Breakout, Dexamethasone,Breakout, Cat\’s eye,Breakout, Loteprednol,Breakout, Ciprofloxacin, Ofloxacin, Peoria-Bloomington IL,100, Champaign & Springfield-Decatur IL,92, Chicago IL,92, Quincy IL-Hannibal MO-Keokuk IA,88, Rockford IL,76, Davenport IA-Rock Island-Moline IL,61, Paducah KY-Cape Girardeau MO-Harrisburg-Mount Vernon IL,57, St. Louis MO,25, Evansville IN,3, Terre Haute IN,, Columbus-Tupelo-West Point MS,100, Hattiesburg-Laurel MS,88, Biloxi-Gulfport MS,85, Greenwood-Greenville MS,79, Jackson MS,76, Memphis TN,17, Meridian MS,, Baton Rouge LA,, Terre Haute IN,100, Indianapolis IN,95, South Bend-Elkhart IN,95, Ft. Wayne IN,84, Evansville IN,59, Louisville KY,29, Chicago IL,5, Cincinnati OH,3, Lafayette IN,, Bowling Green KY,100, Lexington KY,74, Louisville KY,58, Charleston-Huntington WV,29, Evansville IN,27, Paducah KY-Cape Girardeau MO-Harrisburg-Mount Vernon IL,17, Cincinnati OH,7, Knoxville TN,4, Nashville TN,4, Tri-Cities TN-VA,4, Cataract surgery , Knoxville TN,100, Nashville TN,79, Jackson TN,77, Tri-Cities TN-VA,69, Chattanooga TN,65, Memphis TN,63, Gentamicin,+190%, Huntsville-Decatur (Florence) AL,100, Montgomery (Selma) AL,84, Birmingham AL,83, Dothan AL,75, Columbus GA,60, Mobile AL-Pensacola (Ft. Walton Beach) FL,42, Meridian MS,, Dayton OH,100, Cleveland-Akron (Canton) OH,85, Columbus OH,80, Toledo OH,79, Youngstown OH,75, Cincinnati OH,66, Wheeling WV-Steubenville OH,43, Parkersburg WV,37, Lima OH,35, Charleston-Huntington WV,23, Ft. Wayne IN,2, Zanesville OH,, Pilocarpine,Breakout, Saline, similasan eye drops, Dayton OH,100, Cleveland-Akron (Canton) OH,85, Columbus OH,80, Toledo OH,79, Youngstown OH,75, Cincinnati OH,66, Wheeling WV-Steubenville OH,43, Parkersburg WV,37, Lima OH,35, Charleston-Huntington WV,23, Ft. Wayne IN,2, Zanesville OH,, Bluefield-Beckley-Oak Hill WV,100, Charleston-Huntington WV,70, Clarksburg-Weston WV,67, Parkersburg WV,62, Wheeling WV-Steubenville OH,36, Washington DC (Hagerstown MD),2, Harrisonburg VA,, New York,100, New Jersey,99, New Hampshire,93, West Virginia,92, Arkansas,91, Tennessee,90, Alabama,89, Florida,89, Kansas,89, Texas,88, Virginia,87, South Carolina,87, Arizona,87, Louisiana,87, California,86, North Carolina,85, Kentucky,85, Connecticut,84, Nebraska,83, Maryland,83, Oklahoma,83, Michigan,82, Illinois,82, Georgia,82, Utah,81, Ohio,81, Nevada,81, Rhode Island,80, Pennsylvania,80, Wyoming,79, South Dakota,79, New Mexico,78, Missouri,78, Iowa,78, Hawaii,78, Mississippi,76, Colorado,75, Massachusetts,74, North Dakota,74, Indiana,73, Montana,73, Idaho,73, Washington,73, Oregon,73, Minnesota,72, Wisconsin,72, Maine,71, Delaware,68, Alaska,65, District of Columbia,53, Vermont,52, dry eye drops,100, best eye drops,97, pink eye eye drops,68, pink eye drops,68, systane,65, systane eye drops,64, pink eye,63, eye allergy drops,63, refresh,54, refresh eye drops,54, eye drops for dry eyes,51, lumify,44, lumify eye drops,42, pataday eye drops,40, red eye drops,39, eye drops for dogs,38, pataday,37, dog eye drops,35, over the counter eye drops,35, eye drops for pink eye,32, best dry eye drops,30, glaucoma eye drops,29, cvs eye drops,29, prednisolone eye drops,27, antibiotic eye drops,27, olopatadine eye drops otc,Breakout, pataday eye drops cvs,”+1,000%”, chloramphenicol eye drops,+500%, blink tears lubricating eye drops,+500%, refresh relieva eye drops,+450%, tobramycin eye drops for dogs,+350%, flarex eye drops,+350%, naphcon a eye drops,+300%, betimol eye drops,+250%, sananga eye drops,+250%, travoprost eye drops,+250%, allergy eye drops for kids,+250%, polymyxin b tmp eye drops,+250%, kids allergy eye drops,+250%, refresh tears lubricant eye drops,+200%, polyvinyl alcohol,+200%, zioptan eye drops,+190%, prolensa eye drops,+180%, pataday eye drops,+180%, ocuflox eye drops,+170%, liquid msm eye drops,+160%, inveltys eye drops,+140%, xiidra eye drops,+140%, polyvinyl alcohol eye drops,+130%, contact safe eye drops,+130%, Richmond-Petersburg VA,100, Charlottesville VA,85, Roanoke-Lynchburg VA,79, Harrisonburg VA,76, Norfolk-Portsmouth-Newport News VA,71, Washington DC (Hagerstown MD),42, Tri-Cities TN-VA,27, Bluefield-Beckley-Oak Hill WV,, Macon GA,100, Albany GA,67, Atlanta GA,60, Augusta GA,57, Savannah GA,43, Columbus GA,30, Tallahassee FL-Thomasville GA,29, Chattanooga TN,18, Dothan AL,9, Jacksonville FL,3, Tampa-St. Petersburg (Sarasota) FL,100, Ft. Myers-Naples FL,99, West Palm Beach-Ft. Pierce FL,95, Orlando-Daytona Beach-Melbourne FL,93, Miami-Ft. Lauderdale FL,89, Jacksonville FL,87, Panama City FL,86, Gainesville FL,84, Tallahassee FL-Thomasville GA,62, Mobile AL-Pensacola (Ft. Walton Beach) FL,58, Artificial tears,Breakout, Tobramycin / Dexamethasone,Breakout, Bausch + Lomb Soothe XP-Xtra Protection,Breakout, Nasal spray,Breakout, Belladonna,Breakout, Expiration date,Breakout, Meibomian gland,Breakout, Trimethoprim,Breakout, LASIK,Breakout, Ilevro,Breakout, Refresh Plus,Breakout, Walmart Vision & Glasses,Breakout, Prednisolone acetate,Breakout, Erythema,Breakout, Chloramphenicol,Breakout, Flurbiprofen,Breakout, Hydrocortisone,Breakout, Tears,+200%, Ofloxacin,+160%, Timolol,+120%, Itch,+90%, Ketotifen,+80%, Prednisolone,+60%, Olopatadine,+60%, Adverse effect,+40%, Johnstown-Altoona PA,100, Wilkes Barre-Scranton PA,87, Harrisburg-Lancaster-Lebanon-York PA,81, Pittsburgh PA,78, Erie PA,68, Philadelphia PA,55, Elmira NY,26, Youngstown OH,13, Buffalo NY,1, TheraTears,Breakout, Prednisone,Breakout, Ocusoft Retaine MGD Complete Dry Eye Relief,Breakout, Artificial tears,Breakout, Lens,Breakout, Prescription drug,Breakout, Alrex,Breakout, Atropine,Breakout, Saline,Breakout, Corneal abrasion,Breakout, Eyewash,Breakout, Gland,Breakout, SYSTANE,+900%, Side effect,+350%, Visine,+250%, Itch,+250%, Preservative,+250%, Prednisolone,+250%, Pharmaceutical drug,+200%, Tears,+130%, Eye infection,+130%, Olopatadine,+120%, Ofloxacin,+50%, Over-the-counter drug,+40%, Eye,100, Eye drop,95, Drop,77, Dry eye syndrome,16, Dry eye,15, Allergy,10, Contact lens,8, Conjunctivitis,4, Preservative,4, Olopatadine,4, Prednisolone,3, Bausch + Lomb LUMIFY,3, Lens,3, Tears,3, Refresh,2, Ofloxacin,2, Ketotifen,2, Lubricant,2, Over-the-counter drug,2, Visine,2, Antihistamine,2, Infection,2, Cornea,2, Itch,2, Adverse effect,2, Cornea,Breakout, Can-C,Breakout, TheraTears,Breakout, Corneal abrasion,Breakout, Dorzolamide,Breakout, Can-C Lubricant Eye-Drops with Antioxidant N-Acetylcarnosine,Breakout, Dorzolamide / Timolol,Breakout, ICD-10,Breakout, Prescription drug,Breakout, TheraTears Lubricant Eye Drops,Breakout, Ocusoft Retaine MGD Complete Dry Eye Relief,Breakout, Dryness,Breakout, Refresh Tears,Breakout, Systane Preservative-Free Eye Drops,Breakout, Tacrolimus,Breakout, Macular degeneration,Breakout, Cetirizine,Breakout, Cromoglicic acid,Breakout, Fluorometholone,Breakout, Ciprofloxacin/dexamethasone,Breakout, Macula of retina,Breakout, Glaucoma surgery,Breakout, Lens,+150%, Preservative,+130%, Dry eye,+120%, dry eye drops,100, best eye drops,81, systane eye drops,49, allergy eye drops,47, pink eye drops,42, eye drops for dry eyes,38, refresh eye drops,31, prednisolone eye drops,30, lubricant eye drops,27, eye drops for dogs,25, zaditor eye drops,25, visine eye drops,25, eye drops for allergies,24, ofloxacin eye drops,24, eye drops for pink eye,24, best eye drops for dry eyes,22, preservative free eye drops,20, pataday eye drops,20, numbing eye drops,18, timolol eye drops,13, rohto eye drops,13, azelastine eye drops,13, antihistamine eye drops,13, restasis eye drops,11, ciprofloxacin,9, restasis eye drops,Breakout, zerviate eye drops,Breakout, rohto eye drops,+500%, numbing eye drops,+350%, moxifloxacin eye drops,+350%, pataday eye drops,+200%, timolol eye drops,+200%, eye drops for allergies,+190%, best eye drops for dry eyes,+160%, lubricant eye drops,+120%, lumigan eye drops,+110%, eye drops for dry eyes,+100%, dry eye drops,+100%, preservative free eye drops,+90%, prednisolone eye drops,+80%, zaditor eye drops,+70%, systane eye drops,+60%, best eye drops,+50%, eye drops for dogs,+50%, visine eye drops,+50%, azelastine eye drops,+50%, Burlington VT-Plattsburgh NY, Springfield-Holyoke MA,100, Boston MA-Manchester NH,82, Providence RI-New Bedford MA,26, Hartford & New Haven CT, Boston MA-Manchester NH,100, Burlington VT-Plattsburgh NY,65, Portland-Auburn ME,43, Bangor ME,100, Portland-Auburn ME,92, Presque Isle ME, skq1, skq1 supplement, skq1 reddit, skq1 buy, skq1 dry eye, skq1 amazon, skq1 vs mitoq, skq1 bromide, skq1 skin, skq1 eye drops
For search engines / Canada
Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Nunavut, Ontario, Prince Edward Island, Quebec, Saskatchewan, Yukon, Ottawa, Edmonton, Victoria, Winnipeg, Fredericton, St. John's, Halifax, Toronto, Charlottetown, Quebec City, Regina, Yellowknife, Iqaluit, Whitehorse, Airdrie, Beaumont, Brooks, Calgary, Camrose, Chestermere, Cold Lake, Edmonton, Fort Saskatchewan, Grande Prairie, Lacombe, Leduc, Lethbridge, Lloydminster, Medicine Hat, Red Deer, Spruce Grove, St. Albert, Wetaskiwin, Abbotsford, Armstrong, Burnaby, Campbell River, Castlegar, Chilliwack, Colwood, Coquitlam, Courtenay, Cranbrook, Dawson Creek, Delta, Duncan, Enderby, Fernie, Fort St. John, Grand Forks, Greenwood, Kamloops, Kelowna, Kimberley, Langford, Langley, Maple Ridge, Merritt, Nanaimo, Nelson, New Westminster, North Vancouver, Parksville, Penticton,Pitt Meadows, Port Alberni,Port Coquitlam, Port Moody, Powell River, Prince George, Prince Rupert, Quesnel, Revelstoke, Richmond, Rossland, Salmon Arm, Surrey, Terrace, Trail, Vancouver, Vernon, Victoria, West Kelowna, White Rock, Williams Lake, Brandon, Dauphin, Flin Flon, Morden, Portage la Prairie, Selkirk, Steinbach, Thompson, Winkler, Winnipeg, Bathurst, Campbellton, Dieppe, Edmundston, Fredericton, Miramichi, Moncton, Saint John, Corner Brook, Mount Pearl, St. John's, Yellowknife, Iqaluit, Barrie, Belleville, Brampton, Brant, Brantford, Brockville, Burlington, Cambridge, Clarence-Rockland, Cornwall, Dryden, Elliot Lake, Greater Sudbury, Guelph, Haldimand County, Hamilton, Kawartha Lakes, Kenora, Kingston, Kitchener, London, Markham, Peterborough, Pickering, Port Colborne, Prince Edward County, Quinte West, Richmond Hill, Sarnia, Sault Ste. Marie, St. Catharines, St. Thomas, Stratford, Temiskaming Shores, Thorold, Thunder Bay, Timmins, Toronto, Vaughan, Waterloo, Welland, Windsor, Woodstock, Charlottetown, Summerside, Acton Vale, Alma, Amos, Amqui, Baie-Comeau, Baie-D'Urfé, Baie-Saint-Paul, Barkmere, Beaconsfield, Beauceville, Beauharnois, Beaupré, Bécancour, Bedford, Belleterre, Beloeil, Berthierville, Blainville, Boisbriand, Bois-des-Filion, Bonaventure, Boucherville, Lac-Brome, Bromont, Brossard, Brownsburg-Chatham, Candiac, Cap-Chat, Cap-Santé, Carignan, Carleton-sur-Mer, Causapscal, Chambly, Chandler, Chapais, Charlemagne, Châteauguay, Château-Richer, Chibougamau, Clermont, Coaticook, Contrecoeur, Cookshire-Eaton, Côte Saint-Luc, Coteau-du-Lac, Cowansville, Danville, Daveluyville, Dégelis, Delson, Desbiens, Deux-Montagnes, Disraeli,Dolbeau-Mistassini, Dollard-des-Ormeaux, Donnacona, Dorval,Drummondville, Dunham, Duparquet, East Angus, Estérel, Farnham, Fermont, Forestville, Fossambault-sur-le-Lac, Gaspé, Gatineau, Gracefield, Granby, Grande-Rivière, Hampstead, Hudson, Huntingdon, Joliette, Kingsey Falls, Kirkland, La Malbaie, La Pocatière, La Prairie, La Sarre, La Tuque, Lac-Delage, Lachute, Lac-Mégantic, Lac-Saint-Joseph, Lac-Sergent, L'Ancienne-Lorette, L'Assomption, Laval, Lavaltrie, Lebel-sur-Quévillon, L'Épiphanie, Léry, Lévis, L'Île-Cadieux, L'Île-Dorval, L'Île-Perrot, Longueuil, Lorraine, Louiseville, Macamic, Magog, Malartic, Maniwaki, Marieville, Mascouche, Matagami, Matane, Mercier, Métabetchouan–Lac-à-la-Croix, Métis-sur-Mer, Mirabel, Mont-Joli, Mont-Laurier, Montmagny, Montreal, Montreal West, Montréal-Est, Mont-Saint-Hilaire, Mont-Tremblant, Mount Royal, Murdochville, Neuville, New Richmond, Nicolet, Normandin, Notre-Dame-de-l'Île-Perrot, Notre-Dame-des-Prairies, Otterburn Park, Paspébiac, Percé, Pincourt, Plessisville, Pohénégamook, Pointe-Claire, Pont-Rouge, Port-Cartier, Portneuf, Prévost, Princeville, Québec, Repentigny, Richelieu, Richmond, Rigaud, Rimouski, Rivière-du-Loup, Rivière-Rouge, Roberval, Rosemère, Rouyn-Noranda, Saguenay, Saint-Augustin-de-Desmaures, Saint-Basile, Saint-Basile-le-Grand, Saint-Bruno-de-Montarville, Saint-Césaire, Saint-Charles-Borromée, Saint-Colomban, Saint-Constant, Sainte-Adèle, Sainte-Agathe-des-Monts, Sainte-Anne-de-Beaupré, Sainte-Anne-des-Monts, Sainte-Anne-des-Plaines, Sainte-Catherine, Sainte-Catherine-de-la-Jacques-Cartier, Sainte-Julie, Sainte-Marguerite-du-Lac-Masson, Sainte-Marie, Sainte-Marthe-sur-le-Lac, Sainte-Thérèse, Saint-Eustache, Saint-Félicien, Saint-Gabriel, Saint-Georges, Saint-Hyacinthe, Saint-Jean-sur-Richelieu, Saint-Jérôme, Saint-Joseph-de-Beauce, Saint-Joseph-de-Sorel, Saint-Lambert, Saint-Lazare, Saint-Lin-Laurentides, Saint-Marc-des-Carrières, Saint-Ours, Saint-Pamphile, Saint-Pascal, Saint-Pie, Saint-Raymond, Saint-Rémi, Saint-Sauveur, Saint-Tite, Salaberry-de-Valleyfield, Schefferville, Scotstown, Senneterre, Sept-Îles, Shawinigan, Sherbrooke, Sorel-Tracy, Stanstead, Sutton, Témiscaming, Témiscouata-sur-le-Lac, Terrebonne, Thetford Mines, Thurso, Trois-Pistoles, Trois-Rivières, Valcourt, Val-d'Or, Val-des-Sources, Varennes, Vaudreuil-Dorion, Victoriaville, Ville-Marie, Warwick, Waterloo, Waterville, Westmount, Windsor,Estevan, Flin Flon, Humboldt, Lloydminster, Martensville, Meadow Lake, Melfort, Melville, Moose Jaw, North Battleford, Prince Albert, Regina, Saskatoon, Swift Current, Warman, Weyburn, Yorkton.